May 26, 2017 - On May 25, we issued an updated research report on Hampton, NJ-based Celldex Therapeutics, Inc. (CLDX).
May 26, 2017 - The Zacks Analyst Blog Highlights: Merck, 3M, United Technologies, Ford Motor and Humana
May 26, 2017 - A groundbreaking cancer drug approval may not have been what Trump had in mind, but a major restraint has indeed been slashed.
May 26, 2017 - UnitedHealth Group, Inc.???s (UNH) information and technology-enabled health services business "Optum" recently announced its collaboration with Merck & Co. Inc (MRK).
May 26, 2017 - Merck & CO, Inc. (MRK) announced that it has bought exclusive worldwide license from Teijin Pharma for the development, manufacture and commercialization of an investigational preclinical anti-tau antibody.
May 26, 2017 - Merck (MRK) got another approval for Keytruda while Aerie shot up on positive data.
May 25, 2017 - New Stock Research Reports for Merck, 3M and United Technologies
May 25, 2017 - Radius Health, Inc. (RDUS) announced positive data from the ACTIVExtend study on Tymlos demonstrating significant reduction (84%) in the incidence of new vertebral fractures compared to placebo when dosed daily for 43 months.
May 24, 2017 - The following slide deck was published by Merck & Co Inc. in conjunction with this event.
May 24, 2017 - AstraZeneca plc (AZN) announced top-line results from the EXSCEL study evaluating the cardiovascular (CV) safety profile of its type II diabetes drug Bydureon.